UNITY Biotechnology Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon, everybody. My name is Ross Weiner, a biotechnology analyst at Goldman Sachs.
We're pleased to have UNITY Biotechnology with us today, and we'll kick it off.
Questions & Answers
Anirvan, you recently joined UNITY as the new CEO, it would be great if you can give us a brief introduction of yourself and your background and discuss with us what you found compelling about the opportunity at UNITY given your scientific background.
Yes. Thanks, Ross. It's great to be here.
By a way of background, I've been at UNITY as CEO for a little over 2 months now. And immediately, before that, I was the Head of Research and Early Development at Biogen, where we -- I was accountable for the kind of early phase clinical studies. We had a pretty sizable
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
